VESTIBULYaRNAYa MIGREN'


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents data on the epidemiology of vestibular migraine (BM), the types of vertigo occurring in patients with migraine; the hypotheses of occurrence of vestibular symptoms in patients with migraine; diagnostic criteria and current information on the effectiveness of pharmacological and non-pharmacological treatments for the VM. The directions for further research aimed at evaluation of the relationship between migraine and vertigo, and the development of therapeutic approaches to the treatment of VM are discusse.

Full Text

Restricted Access

About the authors

T. A Ivanova

E. G Filatova

Email: eg-filatova@mail.ru

References

  1. Sacks O.W. Migraine: The Evolution of a Common Disorder. London: Faber, 1970.
  2. Living E. On Migrim: Sick Headache and Some Allied Health Disorders. - A Contribution to the Pathology of Nerve Storms. London: Churchill, 1873.
  3. Slater R. Benign recurrent vertigo. J. Neurol. Neurosurg. Psychiatry. 1979; 2: 363-67.
  4. Stolte B, Holle D., Naegel S., Diener H.C., Obermann M. Vestibular migraine. Cephalalgia. 2014.
  5. Cha Y.H., Brodsky J., Ishiyama G., Sabatti C., Baloh R.W. The relevance of migraine in patients with Men' iere's disease. Acta Otolaryngol. (Stockh.) 2007; 127: 1241-45.
  6. Neuhauser H.K. Epidemiology of vertigo. Curr. Opin. Neurol. 2007; 20: 40-60.
  7. Strupp M., Versino M., Brandt T. Vestibular migraine. Handb. Clin. Neurol. 2010; 97: 755-71.
  8. Kelman L., Nanis D. The relationship between migraine pain and other associated symptoms. Cephalalgia. 2006; 26: 548-53.
  9. Jensen R., Stovner L.J. Epidemiology and comorbidity of Headache. Lancet Neurol. 2008; 7: 354-61.
  10. Vukovic V., Plavec D., Galinovic I., Lovrencic-Huzjan A., Budisic M., Demarin V. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache. 2007; 47: 1427-35.
  11. Cherian N. Vertigo as a migraine phenomenon. Curr. Neurol. Neurosci. Rep. 2013; 13(4): 343.
  12. Oh A.K., Lee H., Jen J.C., Corona S., Jacobson K.M., Baloh R.W. Familial benign recurrent vertigo. Am. J. Med. Genet. 2001; 100(4): 287-91.
  13. Cha Y.H., Lee H., Santell L.S., Baloh R.W. Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia. 2009; 29: 550-55.
  14. Neuhauser H., Leopold H.M., von Brevern M., Arnold G., Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001; 56: 436-41.
  15. Celebisoy N., Gö kcay F., Sirin H., Bicak N. Migrainous vertigo: clinical, oculographic and posturographic findings. Cephalalgia. 2008; 28: 72-7.
  16. Bisdorff A. Migraine and dizziness. Curr Opin Neurol. 2014 Feb; 27(1): 105-10.
  17. Lempert T. Vestibular Migraine. Semin in Neurol. 2013; 33(3): 212-18.
  18. Furman J.M., Marcus D.A., Balaban C.D. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013; 12(7): 706-15.
  19. Hirtz D., Thurman D.J., Gwinn-Hardy K. How common are the «common» neurologic disorders? Neurology. 2007; 68: 326-37.
  20. Stolte B., Holle D., Naegel S., Diener H.-C., Obermann M. Vestibular migraine. Cephalalgia. 2015; 35(3): 262-70.
  21. Alexandre R. Bisdorff Management of vestibular migraine. Ther. Adv. Neurol. Disord. 2011; 4(3): 183-91.
  22. Табеева Г.Р., Азимова Ю.Э., Замерград М.В. Современная концепция вестибулярной мигрени (дискуссия). 2012.
  23. Lempert T., Neuhauser H. Migrainous Vertigo. Neurol. Clin. 2005; (23): 715-30.
  24. Lempert T., Neuhauser H. Epidemiology of vertigo, migraine and vestibular migraine J. Neurol. 2009; 256(3): 333-38.
  25. vonBrevan M., Zeise D., Neuhauser H., Clarke A.H., Lempert T. Acute migrainous vertigo: Clin. oculographic findings. Brain. 2005; 128: 365-74.
  26. Замерград М.В. Современные методы медикаментозного лечения вестибулярных нарушений. Фармакотерапия. 2013.
  27. Замерград. М.В. Мигрень-ассоциированное головокружение. Медицинский совет. 2013; 4.
  28. Neuhauser H., Lempert T. Vertigo and dizziness related to migraine: diagnostic challenge. Cephalalgia. 2004; 24: 83-91.
  29. Radtke A., Neuhauser H., von Brevern M., Hottenrott T., Lempert T. Vestibular migraine validity of clinical diagnostic criteria at long-term follow-up. J. Vestib. Res. 2010; 20: 207-08.
  30. Neuhauser H.K., Radtke A., von Brevern M., Feldmann M., Lezius F., Ziese T., Lempert T. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006; 67(6): 1028-33.
  31. Espinosa-Sanchez J.M., Lopez-Escamez J.A. New insights into pathophysiology of vestibular migraine. Front Neurol. 2015; 6: 12.
  32. King S., Wang J., Priesol A., Lewis R. Central integration of canal and otolith signals is abnormal in vestibular migraine. Front Neurol. 2014; 5: 233.
  33. Brandt T., Bronstein A.M. Cervical vertigo. J. Neurol. Neurosurg. Psychiatry. 2001; 71: 8-12.
  34. Obermann M., Strupp M. Current treatment options in vestibular migraine. Front Neurol. 2014; 5: 257.
  35. Mikulec A.A., Faraji F., Kinsella L.J. Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and Complex dizziness of unknown etiology. Am. J. Otolaryngol. 2012; 33(1): 121-27.
  36. Vitkovic J., Winoto A., Rance G., Dowell R., Paine M. Vestibular rehabilitation Outcomes in patients with and without vestibular migraine. J. Neurol. 2013; 260(12): 3039-48.
  37. Goadsby P.J., Zagami A.S., Donnan G.A., Symington G., Anthony M., Bladin P.F., Lance J.W. Oral sumatriptan in acute migraine. Lancet. 1991; 338: 782-83.
  38. Moskowitz M.A. Neurogenic versus vascular mechanism of sumatriptan and ergot alkaloids in migraine. Trends. Pharmacol. Sci. 1992; 13: 307-12.
  39. Цыганков К.Н., Екушева Е.В., Филатова Е.Г. Опыт применения сумамигрена в Клинике головной боли им. акад. Александра Вейна. Лечение нервных болезней. 2007; 3(22): 35-8.
  40. Sumatriptan- an oral dose-defining study.Oral Sumatriptan Dose-defining Study Group. Eur. Neurol. 1991; 31: 300-5.
  41. Pfaffenrath V., Cunin G., Sjonell G., Prendergast S. Efficacy and safety of sumatriptan tablets (25 mg, 50mg, 100 mg) in acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache. 1998; 38: 184-90.
  42. Rederich G., Rapoport A., Cutler N., Hazelrigg R., Jamerson B. Oral Sumatriptan for long-term treatment of migraine: clinical findings. Neurology.1995; 45: 15-20.
  43. Sargent J., Kircher J.R, Davis R., Kirkhart B. Oral Sumatriptan is effective and well tolerated for acute treatment of migraine: results of multicenter study. Neurology. 1995; 45: 10-4.
  44. Международная классификация головной боли (МКГБ-III, бета-версия, 2013).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies